{"id":"vi","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Myalgia"},{"rate":"40-45","effect":"Fatigue"},{"rate":"35-40","effect":"Headache"},{"rate":"35-40","effect":"Injection site erythema"},{"rate":"25-30","effect":"Injection site swelling"},{"rate":"10-15","effect":"Fever"}]},"_chembl":null,"_dailymed":{"setId":"27e377c2-1e68-d4e2-e063-6394a90a2812","title":"ULTRA VIOLETTE MINI MATES DUO PACK (SPF 50) KIT [GRACE AND FIRE USA INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"VI (Shingrix) is a recombinant zoster vaccine containing VZV glycoprotein E antigen combined with an AS01B adjuvant system. It works by priming both CD4+ and CD8+ T-cell responses against varicella zoster virus, providing durable protection against herpes zoster and post-herpetic neuralgia in older adults and immunocompromised populations.","oneSentence":"VI is a varicella zoster virus vaccine that stimulates immune response to prevent herpes zoster (shingles) infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:39.851Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of herpes zoster (shingles) in adults aged 50 years and older"},{"name":"Prevention of herpes zoster in immunocompromised adults aged 18 years and older"}]},"trialDetails":[{"nctId":"NCT03907475","phase":"PHASE2","title":"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":115},{"nctId":"NCT02567435","phase":"PHASE3","title":"Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-06-01","conditions":"Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma","enrollment":325},{"nctId":"NCT00980460","phase":"PHASE3","title":"Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-14","conditions":"PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma","enrollment":236},{"nctId":"NCT07494864","phase":"","title":"Effects of Microbiological and Immunological Factors on the Lower Urinary Tract","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2023-06-01","conditions":"Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter, Recurrent Non-catheter Associated UTIs","enrollment":800},{"nctId":"NCT04801147","phase":"PHASE1, PHASE2","title":"Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2010-06-26","conditions":"Glioblastoma","enrollment":76},{"nctId":"NCT07473674","phase":"NA","title":"This Study Evaluates Skin Response Following Application of a Collagen-based Material in Healthy Adult Volunteers Using a Standardized Skin Prick Test. Skin Responses Will be Assessed at Multiple Time Points Following Application, and the Study is Intended to Evaluate Dermal Safety.","status":"RECRUITING","sponsor":"SerenaGroup, Inc.","startDate":"2026-02","conditions":"Healthy Adult","enrollment":8},{"nctId":"NCT06372496","phase":"PHASE4","title":"Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-04-16","conditions":"Asthma","enrollment":1366},{"nctId":"NCT06353802","phase":"NA","title":"Relationship Between Chronic Non-Specific Neck Pain And Lumbar Reposition Sense","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-09-01","conditions":"Chronic Non-specific Neck Pain","enrollment":67},{"nctId":"NCT03307382","phase":"NA","title":"Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2015-12-15","conditions":"Biliary Stricture","enrollment":40},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT05500482","phase":"PHASE4","title":"Vellore Typhoid Vaccine Impact Trial","status":"COMPLETED","sponsor":"Christian Medical College, Vellore, India","startDate":"2023-05-01","conditions":"Typhoid Fever","enrollment":72400},{"nctId":"NCT07473739","phase":"","title":"AI-Based Ultrasound Prediction of Pregnancy Outcomes in Placental-Related Fetal Growth Restriction (MVM-FGR): A Prospective Cohort Study","status":"RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2023-01-01","conditions":"Fetal Growth Restriction (FGR)","enrollment":300},{"nctId":"NCT06926062","phase":"NA","title":"Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-06-01","conditions":"Human Papillomavirus-Related Carcinoma","enrollment":1900},{"nctId":"NCT04442425","phase":"","title":"Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2020-10-27","conditions":"Cancer, Neoplasms, Solid Tumors","enrollment":83},{"nctId":"NCT07466316","phase":"PHASE3","title":"A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-22","conditions":"Rhabdomyosarcoma","enrollment":342},{"nctId":"NCT05845749","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-09-25","conditions":"MPS IVA, MPS VI","enrollment":6},{"nctId":"NCT07462845","phase":"","title":"Agents Effect Under Visible Light on Caucasian, Asian and Darker Skin Types","status":"COMPLETED","sponsor":"L'Oreal","startDate":"2022-09-05","conditions":"Visible Light Exposure on Healthy Back Skin","enrollment":66},{"nctId":"NCT06917937","phase":"NA","title":"The Additive Effect of Exercise in Addition to Corticosteroid Injection in Plantar Fasciitis","status":"COMPLETED","sponsor":"Kutahya Health Sciences University","startDate":"2018-09-16","conditions":"Plantar Fascitis","enrollment":40},{"nctId":"NCT03660826","phase":"PHASE2","title":"Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-27","conditions":"Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma","enrollment":288},{"nctId":"NCT03570021","phase":"PHASE3","title":"ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2018-08-08","conditions":"Thyroid Cancer","enrollment":352},{"nctId":"NCT02530463","phase":"PHASE2","title":"Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-08","conditions":"Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome","enrollment":99},{"nctId":"NCT07450651","phase":"","title":"Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2026-02","conditions":"Hepatitis B Virus Related Cirrhosis, Portal Hypertension Related to Cirrhosis, Esophagogastric Varices","enrollment":150},{"nctId":"NCT06401330","phase":"PHASE3","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-04-15","conditions":"Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor","enrollment":1656},{"nctId":"NCT06368817","phase":"PHASE2","title":"A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-10-22","conditions":"Basal Ganglia Germinoma, Central Nervous System Germinoma, Diabetes Insipidus","enrollment":240},{"nctId":"NCT02861417","phase":"PHASE2","title":"Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-08-05","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome","enrollment":204},{"nctId":"NCT04194138","phase":"","title":"Complex Adult Deformity Surgery (CADS)","status":"RECRUITING","sponsor":"International Spine Study Group Foundation","startDate":"2018-07-30","conditions":"Adult Spinal Deformity, Scoliosis, Kyphosis","enrollment":1500},{"nctId":"NCT07399301","phase":"NA","title":"High-Intensity Functional Training on Physical Performance and Mental Health in Elderly With Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-01","conditions":"Geriatric Sarcopenia","enrollment":60},{"nctId":"NCT07282886","phase":"PHASE2","title":"VENTURI (VENTilation Using Respiratory Imaging)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-15","conditions":"Asthma","enrollment":20},{"nctId":"NCT07391345","phase":"NA","title":"Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer","status":"RECRUITING","sponsor":"Viktoras Rudzianskas","startDate":"2024-09-01","conditions":"Laryngeal Neoplasm, Glottic Carcinoma","enrollment":105},{"nctId":"NCT07385976","phase":"","title":"The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Far Eastern Memorial Hospital","startDate":"2026-01-19","conditions":"Cervical Cancer, Cervical Intraepithelial Neoplasm, Ovarian Cancer","enrollment":100},{"nctId":"NCT01628029","phase":"PHASE2","title":"Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-01-15","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder","enrollment":68},{"nctId":"NCT07382895","phase":"","title":"The Relationship Between the ASA Score Determined by Operating Room Nurses and Intubation Duration","status":"COMPLETED","sponsor":"Zonguldak Bulent Ecevit University","startDate":"2025-04-01","conditions":"The Individual Must be 18 Years of Age or Older, The Individual Must be Willing to Participate in the Study","enrollment":80},{"nctId":"NCT03153319","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2017-06-05","conditions":"Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI","enrollment":14},{"nctId":"NCT06663436","phase":"PHASE2","title":"A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-11-13","conditions":"Diarrhoea","enrollment":200},{"nctId":"NCT06464549","phase":"","title":"Spontaneous Eye Blinking Evaluation for Cognitive Assessment of Individuals With Severe Acquired Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alfonso Magliacano","startDate":"2025-01-13","conditions":"Disorders of Consciousness, Acquired Brain Injury","enrollment":55},{"nctId":"NCT05397210","phase":"","title":"Post-market Clinical Follow-up (PMCF) Study of the Infinity-Lock Button System for Acromioclavicular Joint Stabilisation","status":"RECRUITING","sponsor":"Xiros Ltd","startDate":"2022-09-26","conditions":"Acromioclavicular; Dislocation","enrollment":58},{"nctId":"NCT04421820","phase":"PHASE1, PHASE2","title":"BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours","status":"RECRUITING","sponsor":"Bold Therapeutics, Inc.","startDate":"2020-08-28","conditions":"Colorectal Cancer, Pancreatic Cancer, Gastric Cancers","enrollment":220},{"nctId":"NCT05057312","phase":"NA","title":"Promoting HPV Vaccination Among Young Adults in Texas","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-07-26","conditions":"Human Papillomavirus Infection","enrollment":1200},{"nctId":"NCT07286370","phase":"PHASE2","title":"A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-02-16","conditions":"Salmonella Infections","enrollment":537},{"nctId":"NCT04918745","phase":"NA","title":"VertiGO! - Get up and GO! With the Vestibular Implant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2021-07-01","conditions":"Bilateral Vestibular Loss","enrollment":13},{"nctId":"NCT07335653","phase":"NA","title":"Evaluation of High-Purity Type I Collagen Biologic Wrap to Improve Function After Extensor Tendon Repair of the Hand","status":"RECRUITING","sponsor":"Adichunchanagiri Institute of Medical Sciences, B G Nagara","startDate":"2025-12-05","conditions":"Injury of Extensor Tendon of Hand, Tendon Adhesions","enrollment":60},{"nctId":"NCT07162194","phase":"NA","title":"MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2025-09-19","conditions":"Prostate Carcinoma","enrollment":130},{"nctId":"NCT06630325","phase":"PHASE2","title":"A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2025-06-24","conditions":"Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma","enrollment":30},{"nctId":"NCT07320716","phase":"PHASE2","title":"Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-01-02","conditions":"Diarrhoea","enrollment":528},{"nctId":"NCT07224880","phase":"","title":"Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists","status":"RECRUITING","sponsor":"Cytrellis Biosystems, Inc.","startDate":"2025-10-14","conditions":"glp1 Agonist, Gene Expression, Skin Laxity","enrollment":10},{"nctId":"NCT05962541","phase":"PHASE4","title":"Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)","status":"RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2025-12-22","conditions":"Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma","enrollment":327},{"nctId":"NCT07310706","phase":"NA","title":"A Study to Evaluate the Efficacy of a Facial Sunscreen in Adult Participants With Oily Skin and Signs of Aging","status":"COMPLETED","sponsor":"Kenvue Brands LLC","startDate":"2025-08-21","conditions":"Oily Skin Aging","enrollment":73},{"nctId":"NCT05919472","phase":"NA","title":"Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women","status":"COMPLETED","sponsor":"Nicole Stoffel","startDate":"2023-07-01","conditions":"Iron Deficiency Anemia","enrollment":180},{"nctId":"NCT06666192","phase":"NA","title":"The Ohio State University (OSU) SCREEN Community Program","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2024-03-12","conditions":"Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma","enrollment":2067},{"nctId":"NCT07296237","phase":"","title":"Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-13","conditions":"Anal Cancer","enrollment":80},{"nctId":"NCT03533582","phase":"PHASE3","title":"Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-24","conditions":"Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma","enrollment":537},{"nctId":"NCT03253692","phase":"","title":"Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2017-10-03","conditions":"Coronary Artery Disease, Coronary Disease, Myocardial Ischemia","enrollment":36},{"nctId":"NCT06817421","phase":"PHASE4","title":"Opportunistic Pneumococcal Immunisation Trial in MALnutrition","status":"NOT_YET_RECRUITING","sponsor":"Nick Fancourt","startDate":"2026-01","conditions":"Severe Acute Malnutrition in Childhood, Pneumococcal Disease, Pneumococcal Vaccines","enrollment":214},{"nctId":"NCT07165925","phase":"NA","title":"Musical Training to Enhance Resilience of Underprivileged School-aged Children","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-09-08","conditions":"Resilience, Depressive Symptom, Anxiety","enrollment":174},{"nctId":"NCT02881086","phase":"PHASE3","title":"Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment","status":"COMPLETED","sponsor":"Goethe University","startDate":"2016-08","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":1023},{"nctId":"NCT06630884","phase":"PHASE1","title":"Inflammatory Challenge and Fear","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-28","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":288},{"nctId":"NCT05493280","phase":"NA","title":"Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-11-14","conditions":"Hyperpigmentation","enrollment":15},{"nctId":"NCT05535972","phase":"PHASE4","title":"To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-10-14","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":463},{"nctId":"NCT07274605","phase":"NA","title":"Comparing the Therapeutic Efficacy of Extended Isthmusectomy Versus Total Thyroidectomy for Isthmus Tumors of the Thyroid","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12-19","conditions":"Thymectomy, Thyroid Cancer","enrollment":520},{"nctId":"NCT05822089","phase":"NA","title":"Intraindividual Comparison of EMO IOLs","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2021-12-13","conditions":"Age Related Cataracts","enrollment":461},{"nctId":"NCT07268300","phase":"","title":"Breast Masses MRI Volumetry Compared to Post-operative Pathological Volume","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":"Breast Masses","enrollment":59},{"nctId":"NCT05073003","phase":"PHASE1","title":"A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-10-06","conditions":"Diarrhoea","enrollment":551},{"nctId":"NCT05480800","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-09-13","conditions":"Salmonella Infections","enrollment":155},{"nctId":"NCT06201728","phase":"NA","title":"The Effect of Asthma Flare-up Clinic After Exacerbation","status":"ENROLLING_BY_INVITATION","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2024-05-01","conditions":"Asthma, Asthma Attack","enrollment":230},{"nctId":"NCT04813718","phase":"NA","title":"Post COVID-19 Syndrome and the Gut-lung Axis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Graz","startDate":"2021-06-02","conditions":"Covid19","enrollment":20},{"nctId":"NCT01961869","phase":"PHASE1","title":"Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2013-07-02","conditions":"Healthy Volunteers","enrollment":67},{"nctId":"NCT05730439","phase":"EARLY_PHASE1","title":"Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-05-19","conditions":"Tobacco-Related Carcinoma","enrollment":71},{"nctId":"NCT01281176","phase":"PHASE1","title":"High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-02-09","conditions":"Adult Solid Neoplasm","enrollment":20},{"nctId":"NCT04604509","phase":"PHASE4","title":"Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-08-04","conditions":"Cigarette Smoking-Related Carcinoma","enrollment":2010},{"nctId":"NCT05757102","phase":"PHASE3","title":"A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2023-04-25","conditions":"Asthma","enrollment":292},{"nctId":"NCT05783271","phase":"NA","title":"Validity of Parametric MRI Using VIRADS","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":"Bladder Cancer","enrollment":58},{"nctId":"NCT03993873","phase":"PHASE1","title":"Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Turning Point Therapeutics, Inc.","startDate":"2019-09-05","conditions":"Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations","enrollment":95},{"nctId":"NCT07197281","phase":"","title":"Perfusion Index and End Diastolic Velocity Ratios as Predictors of Supraclavicular Block Success in Vascular Access Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"End Diastolic Velocity, Perfusion Index","enrollment":50},{"nctId":"NCT07192016","phase":"PHASE4","title":"129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2026-03","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":60},{"nctId":"NCT07190417","phase":"NA","title":"Evaluation of Physiological Effects Induced by Low Level Light Irradiation on the Acupoints of the Hand","status":"COMPLETED","sponsor":"National Yang Ming Chiao Tung University","startDate":"2021-03-05","conditions":"Insomnia, Anxiety, Acupuncture","enrollment":120},{"nctId":"NCT06484335","phase":"PHASE1","title":"RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2025-03-27","conditions":"HIV Infections, PLWH, ART","enrollment":48},{"nctId":"NCT07173530","phase":"NA","title":"Low Level Light Therapy & Skin Pigmentation","status":"RECRUITING","sponsor":"University of Houston","startDate":"2025-06-11","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder)","enrollment":40},{"nctId":"NCT07166484","phase":"","title":"Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype","status":"NOT_YET_RECRUITING","sponsor":"Pierre Fabre Dermo Cosmetique","startDate":"2025-09-15","conditions":"Healthy","enrollment":24},{"nctId":"NCT06548386","phase":"NA","title":"Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks","status":"RECRUITING","sponsor":"Lung Healing Technologies Inc","startDate":"2025-02-05","conditions":"Air Leak From Lung, Pneumothorax","enrollment":33},{"nctId":"NCT04583618","phase":"PHASE2","title":"Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-10-08","conditions":"Pneumococcal Immunization","enrollment":750},{"nctId":"NCT04398706","phase":"PHASE2","title":"Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-05-22","conditions":"Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation","enrollment":852},{"nctId":"NCT07157020","phase":"NA","title":"Research on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09-01","conditions":"Intraventricular Hemorrhage of Prematurity","enrollment":300},{"nctId":"NCT05331248","phase":"NA","title":"Training Local Leaders to Prevent and Reduce Domestic Violence Evidence From Peru","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-05-02","conditions":"Domestic Violence","enrollment":8754},{"nctId":"NCT04651777","phase":"PHASE3","title":"Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-08-08","conditions":"Asthma","enrollment":31},{"nctId":"NCT03156790","phase":"PHASE2","title":"PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"medac GmbH","startDate":"2019-04-26","conditions":"Acute B-Cell Lymphoblastic Leukaemia","enrollment":40},{"nctId":"NCT04937387","phase":"PHASE3","title":"Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-07-29","conditions":"Asthma","enrollment":359},{"nctId":"NCT04713124","phase":"NA","title":"A Telephone-delievered Intervention to Reduce Methamphetamine Use","status":"COMPLETED","sponsor":"Turning Point","startDate":"2021-02-04","conditions":"Methamphetamine Use Disorder","enrollment":204},{"nctId":"NCT07105592","phase":"PHASE1, PHASE2","title":"A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-05-13","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":68},{"nctId":"NCT06156176","phase":"NA","title":"Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial","status":"RECRUITING","sponsor":"Lawson Research Institute of St. Joseph's","startDate":"2025-04-01","conditions":"Long-COVID, Long COVID-19, Post-COVID-19 Syndrome","enrollment":60},{"nctId":"NCT00070564","phase":"PHASE3","title":"S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2003-11","conditions":"Breast Cancer","enrollment":3294},{"nctId":"NCT02498912","phase":"PHASE1","title":"Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-08","conditions":"Solid Tumors","enrollment":18},{"nctId":"NCT05676255","phase":"PHASE2","title":"The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-03-20","conditions":"Breast Cancer Female, Psychological Distress","enrollment":452},{"nctId":"NCT05290857","phase":"NA","title":"Anticoagulation After GI Bleeding Pilot Study and Registry","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-03-31","conditions":"GastroIntestinal Bleeding, Anticoagulant-induced Bleeding","enrollment":100},{"nctId":"NCT07067749","phase":"PHASE3","title":"Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer","status":"RECRUITING","sponsor":"University of Rome Tor Vergata","startDate":"2025-08-15","conditions":"Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy, Bladder Carcinoma","enrollment":92},{"nctId":"NCT07072455","phase":"","title":"Sensory Profile of People With High Intellectual Potential (HIP)","status":"RECRUITING","sponsor":"Centre Hospitalier Esquirol","startDate":"2025-04-01","conditions":"High Intellectual Potential","enrollment":160},{"nctId":"NCT05056077","phase":"NA","title":"Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-21","conditions":"Bladder Cancer, Breast Cancer, Colon Cancer","enrollment":1000},{"nctId":"NCT07066644","phase":"","title":"Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-05-01","conditions":"Thyroid Cancer, Papillary","enrollment":509},{"nctId":"NCT03719092","phase":"NA","title":"High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2020-02-07","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation Recipient","enrollment":62},{"nctId":"NCT06724198","phase":"NA","title":"Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sykehuset Telemark","startDate":"2025-01-01","conditions":"Low Anterior Resection Syndrome, Quality of Life (QOL)","enrollment":20},{"nctId":"NCT05745987","phase":"PHASE4","title":"Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT","status":"RECRUITING","sponsor":"McMaster University","startDate":"2024-09-17","conditions":"Monkeypox","enrollment":3000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"VI","genericName":"VI","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"VI is a varicella zoster virus vaccine that stimulates immune response to prevent herpes zoster (shingles) infection. Used for Prevention of herpes zoster (shingles) in adults aged 50 years and older, Prevention of herpes zoster in immunocompromised adults aged 18 years and older.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}